Portal vein thrombosis after variceal endoscopic sclerotherapy in cirrhotic patients: Role of genetic thrombophilia

Endoscopy

Volumn 34, Issue 7, 2002, Pages 535-538

  Amitrano, L ^a   Brancaccio, V ^a   Guardascione, M A ^a   Margaglione, M ^b   Sacco, M ^a   Martino, R ^a   De Nucci, C ^a   Mosca, S ^a   Iannaccone, L ^a   Ames, P R J ^a   Romano, L ^a   Balzano, A ^a  

^a CARDARELLI HOSPITAL   (Italy)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BLOOD CLOTTING FACTOR 5 LEIDEN; NORFLOXACIN; PHOSPHOLIPID ANTIBODY; POLIDOCANOL; PROTHROMBIN;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; ENDOSCOPIC SCLEROTHERAPY; ESOPHAGUS VARICES BLEEDING; FEMALE; FOLLOW UP; GENE MUTATION; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PORTAL VEIN THROMBOSIS; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THROMBOPHILIA;

AGED; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PORTAL VEIN; RECURRENCE; SCLEROTHERAPY; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 0036294983     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-33210     Document Type: Article

References (32)

1. Incidence of portal thrombosis in liver cirrhosis: An angiographic study in 708 patients
2. Postoperative portal vein obstruction in patients with idiopathic portal hypertension
3. A high incidence of native portal vein thrombosis in veterans undergoing liver transplantation
4. Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis
5. Cause of portal or hepatic venous thrombosis in adults: The role of multiple concurrent factors
6. Obliteration of esophageal varices by PTP: A follow-up of 34 patients
7. Acute portal vein thrombosis, sclerotherapy, and vasopressin: Relationships and implications
8. Endoscopic sclerotherapy: A risk factor for splanchnic venous thrombosis
9. Portal and mesenteric venous thrombosis as a complication of endoscopic sclerotherapy
10. Portal, mesenteric, and splenic venous thrombosis after endoscopic injection sclerotherapy
11. Portal vein thrombosis complicating endoscopic variceal sclerotherapy: Convincing further evidence
12. Portal vein thrombosis following sclerotherapy
13. Endoscopic variceal sclerosis does not increase the risk of portal venous thrombosis
14. Raised plasma fibrinogen concentrations in subjects attending a metabolic ward: Relation to family history and vascular risk factors
15. Activated protein C resistance has an additional risk factor for thrombosis in protein C-deficient families
16. Detection of factor V Leiden mutation using SSCP
17. Factor V Leiden and other coagulation factor mutation affecting thrombotic risk
18. Elevated total plasma homocysteine and C → T mutation of 5,10 methylenetetrahydrofolate reductase gene in thrombotic vascular disease
19. Factor V Leiden, C → T MTHFR polymorphism and genetic susceptibility to preeclampsia
20. Color Doppler ultrasonography in the diagnosis of cavernous transformation of portal vein
21. Portal thrombosis: Dynamic CT features and course
22. Venous thrombosis: A multicausal disease
23. Interrelated risk factors for venous thromboembolism
24. Thrombophilia as a multigenic disease
25. Portal vein thrombosis following endoscopic variceal sclerotherapy
26. Anticardiolipin antibodies in patients with liver disease
27. Factor V Leiden and other coagulation factor mutation affecting thrombotic risk
28. The G20210 A mutation of the prothrombin gene in patients with previous first episodes of deep vein thrombosis: Prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase C677T and plasma prothrombin levels
29. Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: Results of a case-control study
30. Effect of the MTHFR677T variant on risk of venous thromboembolism: Interaction with factor V Leiden and prothrombin (F2G20210A) mutations
31. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
32. Geographic distribution of the 20210 G to A prothrombin variant